Literature DB >> 12437997

PRELP, collagen, and a theory of Hutchinson-Gilford progeria.

Marc Lewis1.   

Abstract

Proline/arginine-rich end leucine-rich repeat protein (PRELP) a small leucine-rich proteoglycan (SLRP), binds type I collagen to basement membranes and type II collagen to cartilage. Evidence for lack of binding of collagen in basement membranes and cartilage of Hutchinson-Gilford progeria (HGP) cases suggests PRELP involvement in that disease. PRELP deficiency is able to account for many symptoms of HGP. Moreover, PRELP also accounts for the fact that unlike many other collagen-related diseases, HGP symptoms are not congenital. The appearance of PRELP sometime after the third month of the birth, coincides with the appearance of HGP symptoms. Hutchinson-Gilford progeria has been diagnosed in twins with a chromosomal inversion at, or very near, the site of the PRELP gene.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12437997     DOI: 10.1016/s1568-1637(02)00044-2

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  12 in total

1.  Functional genetic screen for genes involved in senescence: role of Tid1, a homologue of the Drosophila tumor suppressor l(2)tid, in senescence and cell survival.

Authors:  Marina Tarunina; Lynsey Alger; Grace Chu; Karl Munger; Andrei Gudkov; Parmjit S Jat
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

2.  Characterization of Skin Aging-Associated Secreted Proteins (SAASP) Produced by Dermal Fibroblasts Isolated from Intrinsically Aged Human Skin.

Authors:  Daniel M Waldera Lupa; Faiza Kalfalah; Kai Safferling; Petra Boukamp; Gereon Poschmann; Elena Volpi; Christine Götz-Rösch; Francoise Bernerd; Laura Haag; Ulrike Huebenthal; Ellen Fritsche; Fritz Boege; Niels Grabe; Julia Tigges; Kai Stühler; Jean Krutmann
Journal:  J Invest Dermatol       Date:  2015-03-27       Impact factor: 8.551

Review 3.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

4.  Initial cutaneous manifestations of Hutchinson-Gilford progeria syndrome.

Authors:  Jillian F Rork; Jennifer T Huang; Leslie B Gordon; Monica Kleinman; Mark W Kieran; Marilyn G Liang
Journal:  Pediatr Dermatol       Date:  2014-01-24       Impact factor: 1.588

5.  AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice.

Authors:  M T Birke; E Lipo; M Adhi; K Birke; R Kumar-Singh
Journal:  Gene Ther       Date:  2014-03-27       Impact factor: 5.250

6.  Gene expressions in cerebral palsy subjects reveal structural and functional changes in the gastrocnemius muscle that are closely associated with passive muscle stiffness.

Authors:  Jessica Pingel; Marie-Louise Kampmann; Jeppe Dyrberg Andersen; Christian Wong; Simon Døssing; Claus Børsting; Jens Bo Nielsen
Journal:  Cell Tissue Res       Date:  2021-01-30       Impact factor: 5.249

7.  Potential targets identified in adenoid cystic carcinoma point out new directions for further research.

Authors:  Zhenan Liu; Jian Gao; Yihui Yang; Huaqiang Zhao; Chuan Ma; Tingting Yu
Journal:  Am J Transl Res       Date:  2021-03-15       Impact factor: 4.060

8.  PD-L1-directed PlGF/VEGF blockade synergizes with chemotherapy by targeting CD141+ cancer-associated fibroblasts in pancreatic cancer.

Authors:  Duk Ki Kim; Juhee Jeong; Dong Sun Lee; Do Young Hyeon; Geon Woo Park; Suwan Jeon; Kyung Bun Lee; Jin-Young Jang; Daehee Hwang; Ho Min Kim; Keehoon Jung
Journal:  Nat Commun       Date:  2022-10-22       Impact factor: 17.694

9.  Laser trabeculoplasty induces changes in the trabecular meshwork glycoproteome: a pilot study.

Authors:  Adriana Amelinckx; Maria Castello; Esdras Arrieta-Quintero; Tinthu Lee; Nelson Salas; Eleut Hernandez; Richard K Lee; Sanjoy K Bhattacharya; Jean-Marie A Parel
Journal:  J Proteome Res       Date:  2009-07       Impact factor: 4.466

10.  The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Authors:  Nadia Rucci; Anna Rufo; Marina Alamanou; Mattia Capulli; Andrea Del Fattore; Emma Ahrman; Daria Capece; Valeria Iansante; Francesca Zazzeroni; Edoardo Alesse; Dick Heinegård; Anna Teti
Journal:  J Cell Biol       Date:  2009-11-30       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.